UNSPSC 51112603: Ecomustine

This classification denotes a nitrosourea compound with the molecular formula C10H18ClN3O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7369R4J7S2, chemically known as methyl 3-(3-(2-chloroethyl)-3-nitrosoureido)-2,3-dideoxy-alpha-d-arabino-hexopyranoside but more generally known as ecomustine, which bears US NIH Compound Identifier 65855. European Medicines Agency schedules Ecomustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06449MIG.

UNSPSC 51112603 Ecomustine is a Commodity code covering a pharmaceutical product with limited recent state and local procurement activity. The source provides no recent state or local contract opportunities solicited under this code, no issuing bodies, no geographic spread data, and no representative recent solicitations. Ecomustine is a specialized chemotherapy agent with narrow clinical application; state and local procurement of such products typically flows through health departments, hospital systems, or centralized pharmaceutical purchasing cooperatives rather than as standalone solicitations. Without active recent opportunities in the source record, the code shows minimal current state and local procurement activity worth tracking for business development purposes.

The absence of recent opportunities under this code reflects the specialized nature of the product and the consolidation of pharmaceutical procurement through established group purchasing organizations and state health system contracts. Vendors seeking to supply ecomustine to state and local health care entities should monitor state health department RFPs, hospital system cooperative purchasing vehicles, and group purchasing organization (GPO) solicitations rather than expect direct state or local commodity-level activity under this code.